Oral dyskinesias and striatal lesions in rats after long-term co-treatment with haloperidol and 3-nitropropionic acid

被引:31
作者
Andreassen, OA
Ferrante, RJ
Beal, MF
Jorgensen, HA
机构
[1] Univ Bergen, Sandviken Hosp, Dept Physiol, Bergen, Norway
[2] Univ Bergen, Sandviken Hosp, Dept Psychiat, Bergen, Norway
[3] Bedford VA Med Ctr, Ctr Geriatr Res Educ & Clin, Bedford, MA USA
[4] Boston Univ, Sch Med, Boston, MA 02118 USA
[5] Massachusetts Gen Hosp, Neurol Serv, Neurochem Lab, Boston, MA 02114 USA
[6] Harvard Univ, Sch Med, Boston, MA USA
关键词
neuroleptics; energy impairment; vacuous chewing movements; neurodegeneration; basal ganglia; tardive dyskinesia;
D O I
10.1016/S0306-4522(98)00160-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The pathophysiologic basis of tardive dyskinesia remains unclear. It has been proposed that tardive dyskinesia may be a result of excitotoxic neurodegeneration in the striatum caused by a neuroleptic-induced increase in striatal glutamate release and impaired energy metabolism To investigate this hypothesis, haloperidol decanoate (38 mg/kg/four weeks intramuscularly) and the succinate dehydrogenase inhibitor 3-nitropropionic acid (8 mg/kg/day via subcutaneous osmotic mini-pumps), were administered alone or together for 16 weeks to four-months-old rats. Control rats received sesame oil intramuscularly and had empty plastic tubes subcutaneously. Vacuous chewing movements, a putative analogue to human tardive dyskinesia, were recorded during and after drug treatment. Haloperidol alone, 3-nitropropionic acid alone, and 3-nitropropionic acid+haloperidol treatments induced an increase in vacuous chewing movements. However, Vacuous chewing movements were more pronounced and appeased earlier in rats treated with 3-nitropropionic acid+haloperidol. After drug withdrawal, increases in vacuous chewing movements persisted for 16 weeks in the haloperidol alone and 3-nitropropionic acid+haloperidol group and for four weeks in the 3-nitropropionic acid alone group. Brains from each group were analysed for histopathological alterations. Bilateral striatal lesions were present only in rats with high levels of vacuous chewing movements in the 3-nitropropionic acid+haloperidol-treated rats. Nerve cell depletion and astrogliosis were prominent histopathologic features. There was selective neuronal sparing of both large- and medium-sized aspiny striatal neurons. These results suggest that mild mitochondrial impairment in combination with neuroleptics results in striatal excitotoxic neurodegeneration which may underlie the development of persistent vacuous chewing movements in rats and possibly irreversible tardive dyskinesia in humans. (C) 1998 IBRO. Published by Elsevier Science Ltd.
引用
收藏
页码:639 / 648
页数:10
相关论文
共 46 条
[1]  
American Psychiatric Association Task Force on Tardive Dyskinesia, 1992, TARD DYSK TASK FORC
[2]  
Andreassen O. A., 1995, Society for Neuroscience Abstracts, V21, P470
[3]   GM1 GANGLIOSIDE ATTENUATES THE DEVELOPMENT OF VACUOUS CHEWING MOVEMENTS INDUCED BY LONG-TERM HALOPERIDOL TREATMENT OF RATS [J].
ANDREASSEN, OA ;
JORGENSEN, HA .
PSYCHOPHARMACOLOGY, 1994, 116 (04) :517-522
[4]   Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats [J].
Andreassen, OA ;
Aamo, TO ;
Jorgensen, HA .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (04) :751-757
[5]   THE MITOCHONDRIAL TOXIN 3-NITROPROPIONIC ACID INDUCES VACUOUS CHEWING MOVEMENTS IN RATS - IMPLICATIONS FOR TARDIVE-DYSKINESIA [J].
ANDREASSEN, OA ;
JORGENSEN, HA .
PSYCHOPHARMACOLOGY, 1995, 119 (04) :474-476
[6]   AGING, ENERGY, AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES [J].
BEAL, MF .
ANNALS OF NEUROLOGY, 1995, 38 (03) :357-366
[7]   Oxidative stress-resistant cells are protected against haloperidol toxicity [J].
Behl, C ;
Lezoualch, F ;
Widmann, M ;
Rupprecht, R ;
Holsboer, F .
BRAIN RESEARCH, 1996, 717 (1-2) :193-195
[8]  
Behl C, 1995, NEUROREPORT, V7, P360, DOI 10.1097/00001756-199512000-00085
[9]   AGE-DEPENDENT IMPAIRMENT OF MITOCHONDRIAL-FUNCTION IN PRIMATE BRAIN [J].
BOWLING, AC ;
MUTISYA, EM ;
WALKER, LC ;
PRICE, DL ;
CORK, LC ;
BEAL, MF .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (05) :1964-1967
[10]   NEUROLEPTIC MEDICATIONS INHIBIT COMPLEX-I OF THE ELECTRON-TRANSPORT CHAIN [J].
BURKHARDT, C ;
KELLY, JP ;
LIM, YH ;
FILLEY, CM ;
PARKER, WD .
ANNALS OF NEUROLOGY, 1993, 33 (05) :512-517